Beijing Biostar To Ride HK IPO To Progress Lead Asset In 2L NSCLC

 
• By Dexter Jie Yan
  
chemotherapy
Beijing Biostar is looking for a global partner to take its novel chemo drug utidelone outside of China. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Focus On Asia